Article Also Details Company’s Growth in Mexico, Features In-Depth Interview with Company’s COO
SAN DIEGO, Aug. 16, 2017 /PRNewswire/ — Medical Marijuana, Inc. (MJNA) announced today that its subsidiary HempMeds® Mexico, the first Company to receive government import permits for its cannabidiol (CBD) oil product RSHO-X™ via the Mexican Health Department COFEPRIS, was featured in a Vanity Fair Mexico article highlighting the Company’s expanding presence in Mexico and how its products are helping “improve the quality of life of thousands of patients” with a variety of medical indications, including epilepsy.
The August 14, 2017 article includes an in-depth interview with Chief Operating Officer of HempMeds® Mexico, Carlos Gonzalez, who discusses the Company’s expanding presence in Mexico, research investments and new medical indications to be treated with the Company’s CBD products. The article also discusses in detail how the Company’s RSHO-X™ product has helped change the life of several patients, including one 9-year-old Mexican girl suffering from a severe form of epilepsy known as Lennox-Gastaut syndrome.
“We are always excited to be featured in high-profile media outlets such as Vanity Fair Mexico, as it not only shows the growing acceptance of medicinal cannabis products, but also gets the word out about how our products are truly changing the lives of people suffering,” said Chief Executive Officer of Medical Marijuana, Inc. Dr. Stuart Titus. “It’s an exciting time in terms of CBD in Mexico, where medical marijuana just became officially legalized, and we look forward to our continued investments in the Country.”
Medical Marijuana, Inc.’s HempMeds® Mexico inaugurated its first office in Monterrey, Nuevo Leon, Mexico in June 2017, which serves as the Company’s hub for sales, marketing and distribution of RSHO-X™ to distributors and patients in Mexico.
About HempMeds® Mexico
HempMeds®Mexico is a Mexico-based company that made history by being the first company to receive a COFEPRIS federal government import permit for the cannabis product RSHO-X™ for a medical indication. HempMeds® Mexico plans to work directly with the Mexican government to safely and legally provide access to CBD hemp oil products. For more information, please review the company’s website at: http://www.hempmeds.mx.
About Medical Marijuana, Inc.
Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.’s portfolio and investment companies, visit www.medicalmarijuanainc.com.
FORWARD-LOOKING DISCLAIMER AND DISCLOSURES
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties. The statements in this press release have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease. The Company does not sell or distribute any products that are in violation of the United States Controlled Substances Act. The Company does sell and distribute hemp-based products.
Public Relations Contact:
SOURCE Medical Marijuana, Inc.